SCHEMBL4050540

SCHEMBL4050540

COC(=O)n1ccc2c(Cl)cc(Cl)nc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.38
MAPT P10636 2/20 0.36
ALDH1A1 P00352 2/20 0.36
NPC1 O15118 1/20 0.36
ENPP3 O14638 2/20 0.35
ENPP1 P22413 2/20 0.35
NOTUM Q6P988 2/20 0.35
TSHR P16473 1/20 0.35
LPO P22079 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
SLC22A12 Q96S37 1/20 0.34
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
NR3C1 P04150 1/20 0.33
NR3C2 P08235 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
IGF1R P08069 1/20 0.33
KMT2A Q03164 2/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23147760 0.86 KDM4E (0.36) KDM4EMAPTALDH1A1NPC1LPO
SCHEMBL29721744 0.86 KDM4E (0.36) KDM4EMAPTALDH1A1NPC1LPO
SCHEMBL29680739 0.85 HSP90AA1 (0.49) HSP90AA1HSP90AB1KMT2AMEN1
SCHEMBL24528657 0.85 HSP90AA1 (0.49) HSP90AA1HSP90AB1KMT2AMEN1
SCHEMBL1513230 0.77 PARP1 (0.42) ALDH1A1LPOSLC22A12KMT2AMEN1
SCHEMBL29721895 0.75 LPO (0.33) KDM4EALDH1A1NOTUMLPOSLC22A12
SCHEMBL23147725 0.75 LPO (0.33) KDM4EALDH1A1NOTUMLPOSLC22A12
SCHEMBL4768186 0.73 ALDH1A1 (0.36) KDM4EMAPTALDH1A1NPC1CHRNB4
SCHEMBL31601053 0.73 HSP90AA1 (0.44) KDM4EMAPTALDH1A1HSP90AA1HSP90AB1
SCHEMBL23329532 0.72 HSP90AA1 (0.48) HSP90AA1HSP90AB1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009032703-A1 2- (HET) ARYLAMINO-6-AMINOPYRIDINE DERIVATIVES AND FUSED FORMS THEREOF AS ANAPLASTIC LYMPHOMA KINASE INHIBITORS IRM LLC (BM) 2009-03-12 WO disclosed